Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Consistency of Immunogenicity and Non Inferiority of Three Production Lots of GSK Biologicals' Candidate Malaria Vaccine in Children

NCT01323972 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01323972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01323972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Consistency of Immunogenicity and Non Inferiority of Three Production Lots of GSK Biologicals' Candidate Malaria Vaccine in Children
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
May 16, 2011
Completion date
May 4, 2012
Enrollment
327 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malaria